1Sun LM, Li CI, Huang EY, et al. (2007) Survival differences by race in nasopharyngeal carcinoma. Am J Epidemiology 165:271-278.

2Marks JE, Philips JL, Menck HR (1998) The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma. Cancer 83:582-588.

3Nelson V, Rademaker A, Kaklamani V (2013) Paradigm of polyendocrine therapy in endocrine-responsive breast cancer: the role of fulvestrant. Chin ClinOncol10: 2304-3865.

4Lin A, Swisher-McClure S, Millar LB, et al. (2012) Proton therapy for head and neck cancer: current applications and future directions. Transl Cancer Res 1:255-263.

5Li X, Xiao S, Li Y, et al. (2013) Clinical anti-angiogenic effect of recombinant adenovirus-p53 combined with hyperthermia for advanced cancer. Chin J Cancer Res 25:749-755.

6Chedid HM, Franzi SA, Dedivitis RA, et al. (2008) Assessment of clinical and therapeutic factors in patients with nasopharyngeal undifferentiated carcinoma. Braz J Otorhinolaryngol 74:566-570.

7Chua DT, Ma J, Sham JS, et al. (2006) Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: Subgroup analysis of two Phase III trials. Int J Radiat Oncol Biol Phys 65:1300-1306.

8Cheng SH, Tsai SY, Yen KL, et al. (2000) Concomitant radiotherapy and chemotherapy for early-stage nasopharyngeal carcinoma. J Clin Oncol 18:2040-2045.

9Chua DT, Ma J, Sham JS, et al. (2005) Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phases III trials. J ClinOncol23:1118-1124.

10MB, Edge SB, Greene FL, et al. (2017) eds. AJCC Cancer Staging Manual. 8th ed. New York: Springer 67:93–99.

11Barnes L, Eveson JW, Reichart P, et al. (2005) eds. World Health Organization classification of tumors. Pathology and genetics of head and neck tumors. Lyon: IARC Press 85:74.

12Zhang W, Dou H, Lam C, et al. (2013) Concurrent chemoradiotherapy with or without adjuvant chemotherapy in intermediate and locoregionally advanced nasopharyngeal carcinoma. Tumour Biol 34:1729-1736.

13Ma J, Mai HQ, Hong MH, et al. (2001) Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. J Clin Oncol 19:1350-1357.

14Miller AB, Hoogstraten B, Staquet M, et al. (1981) reporting results of cancer treatment. Cancer 47:207-214.

15Phua CE, Tan BS, Yong TK, et al. (2011) Retrospective analysis of results of treatment for nasopharyngeal carcinoma in Penang General Hospital from 2001-2005. Asian Pac J Cancer Prev 12:3197-3200.

16Kawashima M, Fuwa N, Myojin N, et al. (2004) A multi-institutional survey of the effectiveness of chemotherapy combined with radiotherapy for patients with nasopharyngeal carcinoma. Jpn J Clin Oncol 34:569-583.

17Hui EP, Leung SF, Au JS, et al. (2004) Lung metastasis alone in nasopharyngeal carcinoma: a relatively favorable prognostic group. A study by the Hong Kong Nasopharyngeal Carcinoma Study Group. Cancer 101:300-306.

18Goto Y, Kodaira T, Fuwa N, et al. (2013) Alternating chemoradiotherapy in patients with nasopharyngeal cancer: prognostic factors and proposal for individualization of therapy. J Radiat Res 54:98-107.

19Geara FB, Sanguineti G, Tucker SL, et al. (1997) Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of distant metastasis and survival. Radio Ther Oncol 43:53-61.

20Farias TP, Dias FL, Lima RA, et al. (2003) Prognostic factors and outcome for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 129:794-799.

21Lee AW, Sze WM, Au JS, et al. (2005) Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys 61:1107-1116.

22al-Sarraf M, McLaughlin PW. (1995) Nasopharyngeal carcinoma: choice of treatment. Int J Radiat Oncol Biol Phys 33:761-763.

23Schantz SP, Harrison LB, Forastiere AA (1997) Tumors of the nasal cavity and paranasal sinuses, nasopharynx, oral cavity, and oropharynx. In: DeVita VT, Hellman S, Rosenberg SA. eds. Cancer: Principles and Practice of Oncology. 5th ed. Philadelphia, Pa: Lippincott-Raven 741-801.

24Teo P, Yu P, Lee WY, et al. (1996) Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computed tomography. Int J Radiat Oncol Biol Phys 36:291-304.

25Lee AW, Poon YF, Foo W, et al. (1992) Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 23:261-270.

26Heng DM, Wee J, Fong KW, et al. (1999) Prognostic factors in 677 patients in Singapore with non disseminated nasopharyngeal carcinoma. Cancer 86 1912-1920.

27Marcial VA, Hanley JA, Chang C, et al. (1980) Splitcourse radiation therapy of carcinoma of the nasopharynx: results of a national collaborative clinical trial of the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 6:409- 414.

28Park KH, Kim JS, Park Y, et al. (2010) Concurrent chemoradiation followed by adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma in Korea. Cancer Chemother Pharmacol 66:643-651.

29Chan AT, Teo PM, Ngan RK, et al. (2002) Concurrent chemotherapy-radiotherapy compared with Radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of phase III randomized trial. J Clin Oncol 20:2038-2044.

30Lee AW, Tung SY, Chua DT, et al. (2010) Randomized trial of radiotherapy plus concurrent-adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma. J Natl Cancer Inst 102:1188-1198.

31Chen Y, Sun Y, Liang SB, et al. (2013) Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China. Cancer119:2230-2238.

32Chen L, Hu CS, Chen XZ, et al. (2012) Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomized controlled trial. Lancet Oncol 13:163-171.

33Chen QY, Wen YF, Guo L, et al. (2011) Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial. J Natl Cancer Inst 103:1761-1770.

34J. Daoud, N. Toumi, W. Siala, A. Ghorbel, M. M. Drira, et al. (2007) "Results of a prospective randomized trial comparing conventional radiotherapy to split course fractionated radiation therapy in patients with nasopharyngeal carcinoma," Radiotherapy and Oncology 85:17–23.